2002
DOI: 10.1046/j.1365-2133.2002.05014.x
|View full text |Cite
|
Sign up to set email alerts
|

The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa

Abstract: Peptide antibiotics are present in the vernix caseosa and in the skin of the healthy newborn infant, indicating effective innate immune protection already during fetal and neonatal life.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
92
0
5

Year Published

2004
2004
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 146 publications
(100 citation statements)
references
References 19 publications
3
92
0
5
Order By: Relevance
“…Furthermore, the concentrations of LL-37 at which we observed these effects were consistent with those observed in vivo during inflammation (21)(22)(23), probably produced predominantly by neutrophils and epithelial cells (16,19,22). Although LL-37 expression has also been reported in Langerhans cells, which might also contribute (24), no LL-37 expression was evident at the protein or RNA level in monocyte-derived DC in the immature or mature state (data not shown). It seems likely that this can be attributed to differences between Langerhans cells and monocyte-derived DC, and the cellular milieu.…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…Furthermore, the concentrations of LL-37 at which we observed these effects were consistent with those observed in vivo during inflammation (21)(22)(23), probably produced predominantly by neutrophils and epithelial cells (16,19,22). Although LL-37 expression has also been reported in Langerhans cells, which might also contribute (24), no LL-37 expression was evident at the protein or RNA level in monocyte-derived DC in the immature or mature state (data not shown). It seems likely that this can be attributed to differences between Langerhans cells and monocyte-derived DC, and the cellular milieu.…”
Section: Discussionsupporting
confidence: 69%
“…Expression is significantly up-regulated in the inflamed skin (22), with a median concentration of 304 M (ϳ1.5 mg/ml) in skin lesions from patients with psoriasis (23) and increased by 2-to 3-fold in bronchoalveolar lavage fluid from infants with either systemic or pulmonary inflammation (21). Expression of LL-37 has also been reported in the Langerhans cells of infants with erythema toxicum (24). In addition to its antimicrobial and antiendotoxic activities, it has been reported to be chemotactic for monocytes, T lymphocytes, neutrophils, and mast cells (25,26), and capable of modulating the expression profile of chemokines, chemokine receptors, and additional genes in macrophages and other mammalian cells (27).…”
Section: Endritic Cells (Dc)mentioning
confidence: 92%
“…6 In contrast, it was possible that retention of a highly hydrated biological material such as vernix would impair temperature control due to increased evaporative heat loss. 7 The identification of antimicrobial constituents in vernix [8][9][10][11] supports the intriguing hypothesis that vernix may function prenatally to protect the fetus from acute or subacute chorioamnionitis and facilitate colonization of the skin with microorganisms after birth. Newborn infants undergo a progressive adaptation immediately after birth, including a slow reduction in surface hydration, decrease in skin pH, and SC dehydration/ desquamation with formation of a dry skin surface.…”
Section: Introductionmentioning
confidence: 88%
“…Components of the innate immune repertoire of airway epithelia include human ␤-defensins (HBDs) (7,8) and the only known human cathelicidin, LL-37 (9,10). Defensins and LL-37 are also present in the skin and vernix and contribute to the innate immunity of neonates (11,12). Recently, HBDs and LL-37 were shown to be increased in neonatal tracheal aspirates during infections (13); however, little is known about the development or regulation of human ␤-defensins and cathelicidins in neonatal lung.…”
mentioning
confidence: 99%